Displaying 1 to 20 of 28 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Altheos Inc A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. |
United States | 1 Feb 2012 | Series A Active |
|
|
|
Amira Pharmaceuticals Inc A small molecule pharmaceutical company focused on the discovery and early development of compounds. |
United States | N/A |
||
|
|
Amira Pharmaceuticals Inc A small molecule pharmaceutical company focused on the discovery and early development of compounds. |
United States | N/A |
||
|
|
Asante Solutions Inc Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. |
United States | N/A |
||
|
|
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer |
United States | 7 Aug 2006 | Series A |
|
|
|
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. |
United States | N/A |
||
|
|
Delenex Therapeutics AG |
Switzerland | 1 May 2011 | Series A |
|
|
|
Gloucester Pharmaceuticals Inc |
United States | N/A |
||
|
|
High Throughput Genomics Inc |
United States | 1 Feb 2011 | Series D Active |
|
|
|
Imagen Biotech Inc |
United States | N/A |
||
|
Inogen Inc Developer and manufacturer of homecare products and services for oxygen therapy patients. |
United States | N/A |
||
|
|
Light Sciences Oncology Inc Drug-device cancer therapy |
United States | 1 Dec 2005 | Series A |
|
|
|
Logical Therapeutics Inc An early stage biotechnology company |
United States | N/A |
||
|
|
Lux Biosciences Inc Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. |
United States | N/A |
||
|
|
MediQuest Therapeutics Inc A specialty pharmaceutical company developing topical therapies to treat patients suffering from inflammatory and infectious diseases. |
United States | N/A |
||
|
|
NeuroTherapeutics Pharma Inc |
United States | N/A |
||
|
|
Ophthotech Corp Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. |
United States | N/A |
||
|
|
Orphazyme ApS Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. |
Denmark | 14 Feb 2011 | Seed Initial investment. Round participant. Active |
|
|
|
Orphazyme ApS Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. |
Denmark | 1 Sep 2011 | Series A Follow-on investment. Round participant. Active |
|
|
|
Panmira Pharmaceuticals LLC Pharmaceutical company for inflammatory diseases. |
United States | N/A |